Related Experiment Video
Updated: May 31, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
STXBP1-related encephalopathy presenting as infantile spasms and generalized tremor in three patients
Cyril Mignot1, Marie-Laure Moutard, Oriane Trouillard
1Clinical Genetic Unit Pitié-Salpêtrière Hospital, AP-HP, Paris, France. cyril.mignot@psl.aphp.fr
Insights
Mutations in the STXBP1 gene cause severe infantile epileptic encephalopathy. Early diagnosis and treatment of STXBP1-related disorders, characterized by infantile spasms and tremor, are crucial for improved outcomes.
Area of Science:
- Genetics
- Neurology
- Pediatrics
Background:
- Dominant mutations in the STXBP1 gene are a newly identified cause of infantile epileptic encephalopathy.
- STXBP1-related encephalopathy presents without metabolic or structural brain anomalies.
- Previous reports identified 25 patients with STXBP1 mutations, mostly diagnosed with Ohtahara syndrome or infantile spasms.
Observation:
- This study analyzed 29 patients with early-onset epileptic encephalopathy and normal metabolic/chromosomal workups.
- Two patients had de novo heterozygous STXBP1 mutations (p.Arg406His and a premature termination codon).
- A third patient with infantile epileptic encephalopathy and nail malformations had a 3-3.5 Mbp deletion detected by CGH array.
Findings:
- All three patients exhibited infantile spasms with focal seizures, responding to antiepileptic drugs.
- Severe intellectual disability was observed in all affected individuals.
- Generalized tremor was a prominent neurological feature, with one patient also showing an akinetic-hypertonic syndrome.
Implications:
- STXBP1 mutations are a significant cause of infantile epileptic encephalopathies.
- STXBP1-related encephalopathy can manifest as drug-responsive infantile spasms with focal discharges.
- The onset of generalized tremor after the first year of life may indicate STXBP1-related encephalopathy.
Purpose:
Dominant mutations in the STXBP1 gene are a recently identified cause of infantile epileptic encephalopathy without metabolic and structural brain anomalies. To date, 25 patients with heterozygous mutation or deletion of STXBP1 have been reported. A diagnosis of early infantile epileptic encephalopathy with suppression-burst (Ohtahara syndrome) was made in most of them, with infantile spasms and nonsyndromic infantile epileptic encephalopathy being the diagnosis in other patients. Although the phenotypic spectrum of STXBP1-related encephalopathy is emerging with evidence suggesting the relatively frequent involvement of this gene in infantile epileptic encephalopathies, accurate clinical descriptions of patients are still necessary to delineate this entity.
Methods:
The sequence of the STXPB1 gene was analyzed in 29 patients with early onset syndromic or nonsyndromic infantile epileptic encephalopathy without brain magnetic resonance imaging (MRI) anomalies and with normal chromosomal and metabolic checkup. Another patient with a complex phenotype was analyzed by comparative genomic hybridization (CGH) array.
Key Findings:
From the studied series, 2 of 29 patients were found to carry a de novo heterozygous mutation in STXBP1. One patient carried the recurrent p.Arg406His mutation and the other an insertion of 10 bases leading to a premature termination codon. CGH array experiment detected a deletion of 3-3.5 Mbp in the third patient with infantile epileptic encephalopathy and nail malformations. All three had infantile spasms associated with partial seizures that responded to antiepileptic drug therapy. Intellectual abilities were severely impaired in all of them. Generalized tremor was the main neurologic striking feature in the three patients, with one of them further displaying unilateral akinetic-hypertonic syndrome.
Significance:
Mutations in STXBP1 are relatively frequent in patients with infantile epileptic encephalopathies. STXBP1-related encephalopathy may present as drug-responsive infantile spasms with focal/lateralized discharges. Generalized tremor appearing after the first year of life may be a clue to the diagnosis in some patients.
Related Concept Videos
Tetanus
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Botulism
Huntington Disease l: Introduction
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Alterations in Muscle Tone lll

